Pharmsville Co., Ltd. (KOSDAQ:318010)
3,640.00
0.00 (0.00%)
At close: Sep 11, 2026
Pharmsville Market Cap
Pharmsville has a market cap or net worth of 28.13 billion as of September 11, 2026. Its market cap has decreased by -9.23% in one year.
Market Cap
28.13B
Enterprise Value
-7.49B
Revenue
11.20B
Ranking
n/a
PE Ratio
9.41
Stock Price
3,640.00
ChartMarket Cap Chart
Since October 22, 2019, Pharmsville's market cap has decreased from 113.79B to 28.13B, a decrease of -75.28%. That is a compound annual growth rate of -18.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 28.13B | 5.97% |
| Dec 30, 2025 | 26.55B | -8.28% |
| Dec 30, 2024 | 28.94B | -57.01% |
| Dec 28, 2023 | 67.32B | -21.29% |
| Dec 29, 2022 | 85.53B | -20.44% |
| Dec 30, 2021 | 107.50B | 25.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneBioTech Co. ,Ltd | 41.55B |
| Eagle Veterinary Technology Co.,Ltd | 39.76B |
| Korea Arlico Pharm | 38.01B |
| Korean Drug | 36.99B |
| HLscience | 26.99B |
| Baskhanbio Pharma | 25.20B |
| Daesung Microbiological Labs. | 23.33B |
| Seoul Pharma | 22.81B |